Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRAP1 | Q12931 | 5/20 | 0.40 |
| ▸ | HSP90B1 | P14625 | 4/20 | 0.40 |
| ▸ | FGFR4 | P22455 | 4/20 | 0.39 |
| ▸ | KRAS | P01116 | 10/20 | 0.38 |
| ▸ | SPR | P35270 | 1/20 | 0.36 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31335695 | 0.90 | TRAP1 (0.40) | TRAP1HSP90B1FGFR4KRASSPR | |
| SCHEMBL31335618 | 0.90 | SPR (0.39) | TRAP1HSP90B1KRASSPR | |
| SCHEMBL31335640 | 0.88 | FGFR4 (0.35) | TRAP1HSP90B1FGFR4KRASSPR | |
| SCHEMBL31335522 | 0.88 | TRAP1 (0.38) | TRAP1HSP90B1FGFR4KRASSPR | |
| SCHEMBL31335782 | 0.87 | FGFR1 (0.37) | TRAP1HSP90B1FGFR4KRASSPR | |
| SCHEMBL31335781 | 0.85 | TRAP1 (0.39) | TRAP1HSP90B1SPR | |
| SCHEMBL25216773 | 0.85 | TRAP1 (0.38) | TRAP1HSP90B1KRASSPR | |
| SCHEMBL30970481 | 0.85 | TRAP1 (0.38) | TRAP1HSP90B1KRASSPR | |
| SCHEMBL31335582 | 0.84 | TRAP1 (0.48) | TRAP1HSP90B1FGFR4KRAS | |
| SCHEMBL31335555 | 0.82 | SPR (0.39) | TRAP1HSP90B1SPR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4720038-A1 | (HETERO)ARYL-CARBONYL-HETEROBICYCLIC COMPOUNDS AS INHIBITORS OF PMS2 FOR CANCER AND DEGENERATIVE ILLNESSES | Neophore Limited (GB) | 2026-04-08 | — | — | EP | claimed |
| WO-2024246496-A1 | (HETERO)ARYL-CARBONYL-HETEROBICYCLIC COMPOUNDS AS INHIBITORS OF PMS2 FOR CANCER AND DEGENERATIVE ILLNESSES | Neophore Limited (GB) | 2024-12-05 | — | — | WO | claimed |
| EP-4720038-A1 | (HETERO)ARYL-CARBONYL-HETEROBICYCLIC COMPOUNDS AS INHIBITORS OF PMS2 FOR CANCER AND DEGENERATIVE ILLNESSES | Neophore Limited (GB) | 2026-04-08 | — | — | EP | disclosed |
| WO-2024246496-A1 | (HETERO)ARYL-CARBONYL-HETEROBICYCLIC COMPOUNDS AS INHIBITORS OF PMS2 FOR CANCER AND DEGENERATIVE ILLNESSES | Neophore Limited (GB) | 2024-12-05 | — | — | WO | disclosed |